ARMC5 p.Arg315Trp
c.943C>T · VCV3602762
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9562 | likely pathogenic ✓ concordant with ClinVar · top 7% in ARMC5 |
|---|---|---|
| REVEL | 0.703 | pathogenic-leaning |
| SaProt | LLR -13.53 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.2 | GERP 1, phastCons 1 |
| Regional constraint | o/e 0.80 | unconstrained · MANE · 4,961 bp · p 1.6e-10 · regional, not allelic |
| Overall | ||
| CADD | 24.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.00483% | 20,702 |
| European (non-Finnish)grpmax | 0.00017% | 589,908 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ARMC5
- Protein
- p.Arg315Trp
- Coding
- c.943C>T
- MANE Select
- NM_001105247
- Type
- single nucleotide variant
- Location
- chr16:31462490 (GRCh38)
- Gene constraint
- LOEUF 0.772 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 81.27
- Residue 315
- a UniProt-annotated variant site (in aimah2; uncertain significance); a UniProt-annotated variant site (in aimah2); a UniProt-annotated variant site (in aimah2; loss of function in promoting apoptosis; decreased association with polr2a component of rna polymerase ii; reduced ability to promote degradation of srebf1)
Disease context
ACTH-independent macronodular adrenal hyperplasia 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Cushing syndrome due to bilateral macronodular adrenocortical disease (Orphanet):
- Inheritance
- Autosomal dominant, Not applicable
- Onset
- All ages
- Prevalence
- <1 / 1 000 000 (Europe)
Similar variants
- ARMC5 p.Arg315Pro Likely pathogenic ★ same residue
- ARMC5 p.Trp801Cys Uncertain significance ★★ ⚠ same condition
- ARMC5 p.Ala243= Benign/Likely benign ★★ same condition
- ARMC5 p.Leu156Phe Benign/Likely benign ★★ ⚠ same condition
- ARMC5 p.Arg267Ter Pathogenic ★ same condition
- ARMC5 p.Arg364Ter Pathogenic ★ same condition
- ARMC5 p.Arg764Ter Pathogenic ★ same condition
- ARMC5 p.Glu833Ter Likely pathogenic ★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/armc5-p-arg315trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown